News & Updates
Faces of Lung Cancer Report
Reflection of COVID-19. The annual report is now available!
Cancer patient groups across Canada call for 2nd COVID-19 dose to be given to cancer patients according to best evidence- 21 to 28 days, not 4 weeks.
Alberta approves 21 or 28 day COVID-19 vaccine interval for cancer patients on active treatment
Lymphoma Canada, Myeloma Canada, Save Your Skin Foundation and Lung Cancer Canada ask the Provincial Governments for timely administration of second COVID-19 vaccines for immunocompromised patients, prioritization of the vaccine for household members of patients receiving immunosuppressive therapy, and increased guidance on the COVID-19 vaccine specific for cancer patients.
Join lung cancer patients around the world who are sharing their experience of lung cancer care.
New Ontario VCAG recommendations for COVID-19 vaccine intervals for cancer patients.
RELEASE (Toronto/ March 11, 2021)
A panel discussion of the latest advances in immunotherapy for the treatment of lung cancer. Featuring Dr. Julie Brahmer and Dr. Rosalyn Juergens. Moderated by Dr. Paul Wheatley-Price.
Get answers to your questions and links to provincial rollout plans
Dr. Justin Gainor and Dr. Cheryl Ho discuss what's new from the Canadian Lung Cancer Conference. Moderated by Dr. Paul Wheatley-Price.
A new report from CPAC and follow up Lung Cancer Voices podcast!